Literature DB >> 3936724

Seizure control following administration of anticonvulsant drugs in the quaking mouse.

S M Taylor, G D Bennett, L C Abbott, R H Finnell.   

Abstract

The effectiveness of a variety of clinical anticonvulsant drugs was evaluated in the quaking mutant mouse model of epilepsy. In this model, tonic-clonic seizures are easily elicited by handling and the effects of administration of carbamazepine (CBZ), phenytoin (DPH), phenobarbital (PB), diazepam, valproic acid (VPA) and ethosuximide were quantitatively evaluated. Chronic oral administration of CBZ, DPH and PB reduced the frequency of seizures and this was positively correlated with plasma levels of the drugs. The plasma levels of the 10,11-epoxide metabolite of CBZ were found to be approximately 3-5 times that of the parent compound with chronic oral administration. Acute intraperitoneal administration of the other drugs revealed VPA to be an effective anticonvulsant agent, whereas ethosuximide and diazepam were ineffective at dosage levels that are normally effective in mice as determined by classical testing methods such as electroshock and chemoshock. The results of the present study suggest that the quaking mouse may be a simple, reliable and inexpensive animal model for the evaluation of agents effective against focal motor seizures in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936724     DOI: 10.1016/0014-2999(85)90675-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Effect of denzimol on carbamazepine and carbamazepine-10,11-epoxide concentrations in serum, liver, spleen and different brain regions of the rat: an inhibitory metabolic interaction.

Authors:  P N Patsalos; M S Alavijeh; W Brownhill; P T Lascelles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

2.  Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats.

Authors:  J Dingemanse; R A Voskuyl; M W Langemeijer; I Postel-Westra; D D Breimer; H Meinardi; M Danhof
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure.

Authors:  J Dingemanse; F A Sollie; D D Breimer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

4.  Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.

Authors:  B Delaloye; A Bischof-Delaloye; F Buchegger; V von Fliedner; J P Grob; J C Volant; J Pettavel; J P Mach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival.

Authors:  Christina Gavino; Stéphane Richard
Journal:  Sci Rep       Date:  2011-09-06       Impact factor: 4.379

6.  Drug repositioning in epilepsy reveals novel antiseizure candidates.

Authors:  Leo Brueggeman; Morgan L Sturgeon; Russell M Martin; Andrew J Grossbach; Yasunori Nagahama; Angela Zhang; Mathew A Howard; Hiroto Kawasaki; Shu Wu; Robert A Cornell; Jacob J Michaelson; Alexander G Bassuk
Journal:  Ann Clin Transl Neurol       Date:  2018-12-11       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.